StemCells, Inc. is a public
biopharmaceutical company headquartered in Newark, California, that is developing purified human
neural stem cells (HuCNS-SCs) in the hopes of treating
central nervous system disorders and
paralysis
Paralysis (also known as plegia) is a loss of motor function in one or more muscles. Paralysis can also be accompanied by a loss of feeling (sensory loss) in the affected area if there is sensory damage. In the United States, roughly 1 in 50 ...
. StemCells' HuCNS-SCs have the ability to
differentiate into the three main types of cells found in the central nervous system:
neurons
A neuron, neurone, or nerve cell is an electrically excitable cell that communicates with other cells via specialized connections called synapses. The neuron is the main component of nervous tissue in all animals except sponges and placozoa. N ...
,
astrocytes and
oligodendrocytes.
They are being studied in early stage trials.
In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.
References
External links
StemCells, Inc. website
{{Authority control
Biotechnology companies of the United States